Key Points
- CEO Eric Lefkofsky sold 250,000 Tempus AI shares at an average price of $70.36, generating approximately $17.59 million. The transaction was made under a pre-arranged Rule 10b5-1 trading plan and reduced his ownership by 83.33% to 50,000 shares.
- Tempus AI reported quarterly revenue of $382.49 million, up 21.6% year over year, and an adjusted loss of $0.04 per share that exceeded analysts’ expectations. Analysts expect the company to post a full-year loss of $1.45 per share.
- Analyst sentiment remains mixed: the stock has a consensus “Hold” rating and an average price target of $72.47, while institutional investors own 24.22% of the company.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $70.36, for a total value of $17,590,000.00. Following the transaction, the chief executive officer owned 50,000 shares of the company's stock, valued at $3,518,000. This represents a 83.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Tempus AI Stock Up 1.6%
TEM stock opened at $77.84 on Friday. Tempus AI, Inc. has a 1-year low of $40.77 and a 1-year high of $91.83. The business's 50 day simple moving average is $70.58 and its 200 day simple moving average is $57.05. The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06. The firm has a market capitalization of $14.04 billion, a PE ratio of -54.06 and a beta of 3.54.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%. The business had revenue of $382.49 million during the quarter, compared to the consensus estimate of $379.69 million. During the same quarter last year, the firm posted ($0.22) EPS. The company's quarterly revenue was up 21.6% on a year-over-year basis. As a group, research analysts anticipate that Tempus AI, Inc. will post -1.45 EPS for the current year.
Institutional Investors Weigh In On Tempus AI
Hedge funds and other institutional investors have recently modified their holdings of the company. Guardian Partners Inc. boosted its position in shares of Tempus AI by 8.3% in the third quarter. Guardian Partners Inc. now owns 2,600 shares of the company's stock valued at $213,000 after acquiring an additional 200 shares during the period. V Square Quantitative Management LLC acquired a new stake in Tempus AI in the 3rd quarter worth about $27,000. ProShare Advisors LLC grew its position in shares of Tempus AI by 5.9% during the 3rd quarter. ProShare Advisors LLC now owns 6,500 shares of the company's stock worth $532,000 after purchasing an additional 360 shares in the last quarter. Cyndeo Wealth Partners LLC increased its holdings in shares of Tempus AI by 6.7% during the third quarter. Cyndeo Wealth Partners LLC now owns 6,412 shares of the company's stock worth $525,000 after purchasing an additional 400 shares during the period. Finally, Arkadios Wealth Advisors increased its holdings in shares of Tempus AI by 9.6% during the first quarter. Arkadios Wealth Advisors now owns 4,963 shares of the company's stock worth $224,000 after purchasing an additional 435 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.
Analysts Set New Price Targets
A number of research firms have recently issued reports on TEM. Lake Street Capital cut shares of Tempus AI to a "hold" rating in a research note on Monday, July 20th. Weiss Ratings upgraded shares of Tempus AI from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Tuesday, October 13th. Piper Sandler raised shares of Tempus AI from a "neutral" rating to an "overweight" rating and increased their price target for the company from $56.00 to $76.00 in a report on Tuesday, September 1st. Needham & Company LLC reissued a "buy" rating and issued a $75.00 price target on shares of Tempus AI in a report on Friday, October 23rd. Finally, Guggenheim raised their price objective on shares of Tempus AI from $65.00 to $92.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Eleven investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $72.47.
Get Our Latest Analysis on Tempus AI
About Tempus AI
(
Get Free Report)
Tempus AI, Inc is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies.
Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
